NationStates Jolt Archive

LifeWyze BioTech today announced that its' research into TGN1412 and a look at its' potential applications has led to its' development as a new biological weapon.

Originally research on TGN1412 was bought from TeGenero Immuno Therapeutics. While LifeWyze vowed to perfect it with the view of bringing it to its' proposed purpose of treating rheumatoid arthritis and B-cell leukemia, it would seem that such development has not been undertaken.

TGN1412 almost killed 6 people when it was tested in March 2006, leading to a worldwide investigation into TeGenero Immuno Therapeutics practices. The drug began affecting the immune system of test subjects roughly twelve minutes after administration, causing major organ failure, as well as swelling of the skin and mucous membrane.

BBC coverage of TGN1412 (http://news.bbc.co.uk/1/hi/health/5015224.stm)

The new TGN1412, rebranded ImmunYze, is due to go on sale some time in the next week.

CRYPTOGRAM Message:

I must infrom you that I am writing to this in utter secracy. i'm A General in the Kurona Army, and looking for more powerful weapons. Our ruler still disapproves, but we think with a little time and efforts we can demonstrate potental. I realize this isn't on sale yet, but we would like to put in a reservation for 12 cases.

Sincerly,

General D. Eric VaunBraun

(OOC: I would like to direct you to the LifeWyze BioTech storefront, link in my signature, where the modified TGN1412 has just been added to the biological weapons area. *Smiles*)

(OOC: I was going to make further requests but figured I should get approved first. TO THE STORE FRONT)